| For: | Xia Y, Lin RX, Zheng SJ, Yang Y, Bo XC, Zhu DY, Wang SQ. Effective siRNA targets screening for human telomerase reverse transcriptase. World J Gastroenterol 2005; 11(16): 2497-2501 [PMID: 15832425 DOI: 10.3748/wjg.v11.i16.2497] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i16/2497.htm |
| Number | Citing Articles |
| 1 |
Xiaoping Tian, Bo Chen, Xiaochuan Liu. Telomere and Telomerase as Targets for Cancer Therapy. Applied Biochemistry and Biotechnology 2010; 160(5): 1460 doi: 10.1007/s12010-009-8633-9
|
| 2 |
J. Manuel Perez, Jan Grimm, Lee Josephson, Ralph Weissleder. Integrated Nanosensors to Determine Levels and Functional Activity of Human Telomerase. Neoplasia 2008; 10(10): 1066 doi: 10.1593/neo.08350
|
| 3 |
LINHU GE, WENLONG SHAO, YANGDE ZHANG, YUAN QIU, DONG CUI, DONGHAI HUANG, ZHANSHENG DENG. RNAi targeting of hTERT gene expression induces apoptosis and inhibits the proliferation of lung cancer cells. Oncology Letters 2011; 2(6): 1121 doi: 10.3892/ol.2011.388
|
| 4 |
Irmina Diala, Yasuo Shiohama, Takashi Fujita, Yojiro Kotake, Constantinos Demonacos, Marija Krstic-Demonacos, Gianpiero Di Leva, Masayuki Fujii. Telomerase inhibition, telomere attrition and proliferation arrest of cancer cells induced by phosphorothioate ASO-NLS conjugates targeting hTERC and siRNAs targeting hTERT. Nucleosides, Nucleotides & Nucleic Acids 2020; 39(1-3): 407 doi: 10.1080/15257770.2020.1713357
|
| 5 |
Dilpreet Singh. mRNA-Encoded antibodies as a next-generation therapeutic paradigm: a rapid and adaptive platform for the prevention and treatment of emerging and re-emerging infectious diseases — A critical review. Immunologic Research 2026; 74(1) doi: 10.1007/s12026-025-09737-z
|
